Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 to 90 years old
- People who have a previously diagnosed glioblastoma (a type of brain tumour), classified according to the 2021 World Health Organisation brain tumour guidelines, that has come back after earlier treatment
- People whose tumour is located in or close to important brain areas that control movement, sensation, speech, or vision, as shown on an MRI scan
- People whose tumour is considered suitable for surgical removal, as determined by a neurosurgeon
- People who are able to provide written agreement to participate in the trial
Who may not be able to join:
- People whose tumour is located in the cerebellum, brainstem, or along the midline of the brain
- People who have multiple tumour spots showing up on contrast-enhanced imaging (a type of detailed scan)
- People who cannot have an MRI scan for medical reasons, such as having a pacemaker
- People who are unable to provide written consent to participate
- People whose high-grade brain tumour developed as a result of a lower-grade tumour changing over time (known as malignant transformation)
- People for whom the necessary medical information from their original diagnosis is not available (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jasper Gerritsen, MD PhD, Erasmus Medical Center
Phone: +31107036130
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Residual volume; Neurological morbidity at 6 weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.